Patents by Inventor Junichi Hosoi

Junichi Hosoi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AGENT FOR PREVENTING AND/OR IMPROVING PHOTOAGING AND/OR DERMAL PIGMENTATION, COSMETIC METHOD USING SAME, AND COSMETIC DEVICE TO BE APPLIED IN SAID METHOD
    Publication number: 20230172837
    Abstract: The present invention provides an agent for preventing and/or improving photoaging and/or dermal pigmentation comprising Thujae Semen extract as an active ingredient. The present invention also provides a cosmetic method which includes a step for applying the agent for preventing and/or improving photoaging and/or dermal pigmentation to skin to be treated, and a cosmetic device to be applied in said method.
    Type: Application
    Filed: April 19, 2021
    Publication date: June 8, 2023
    Applicant: SHISEIDO COMPANY, LTD.
    Inventors: Satoshi HORIBA, Junichi HOSOI, Daigo INOUE, Kentaro KAJIYA, Masaya TAKAGI, Yuko MATSUURA, Masato IINO
  • Agent for sedating response to external stimulation in skin and method for sedating that response
    Patent number: 10617710
    Abstract: An object of the present invention is to provide an agent for sedating the response of skin to external stimulation. The aforementioned object was achieved by finding a component that promotes CD39 gene expression in Langerhans cells. More specifically, the present invention is based on the finding that the combination of carboxymethyl-beta glucan or a salt thereof polyoxyethylene (POE)/polyoxypropylene (POP) random copolymer dimethyl ether and rosewater promotes CD39 gene expression.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 14, 2020
    Assignee: Shiseido Company, Ltd.
    Inventors: Junichi Hosoi, Kaori Inoue, Shoko Yamada, Minako Sato
  • AGENT FOR SEDATING RESPONSE TO EXTERNAL STIMULATION IN SKIN AND METHOD FOR SEDATING THAT RESPONSE
    Publication number: 20170014444
    Abstract: An object of the present invention is to provide an agent for sedating the response of skin to external stimulation. The aforementioned object was achieved by finding a component that promotes CD39 gene expression in Langerhans cells. More specifically, the present invention is based on the finding that the combination of carboxymethyl-beta glucan or a salt thereof polyoxyethylene (POE)/polyoxypropylene (POP) random copolymer dimethyl ether and rosewater promotes CD39 gene expression.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 19, 2017
    Applicant: SHISEIDO COMPANY, LTD
    Inventors: Junichi HOSOI, Kaori INOUE, Shoko YAMADA, Minako SATO
  • Skin immune function controlling agents
    Publication number: 20050287232
    Abstract: Disclosed are skin immune function controlling agents which contain as the active ingredient a volatile substance capable of stimulating the olfactory receptor, as typified by a specific perfume. By controlling the skin immune function, these agents serve, for example, to enhance the skin barrier function and to prevent or treat skin contact hypersensitivity.
    Type: Application
    Filed: August 24, 2005
    Publication date: December 29, 2005
    Inventors: Junichi Hosoi, Toru Tsuchiya